Paramagnetic species in the plasma of dogs with lymphoma prior to and after treatment with doxorubicin: An ESR study

Biochemical Pharmacology

Volumn 64, Issue 12, 2002, Pages 1737-1744

  Gille, Lars ^a   Kleiter, Miriam ^a   Willmann, Michael ^a   Nohl, Hans ^a  

^a UNIVERSITY OF VETERINARY MEDICINE   (Austria)

Author keywords

Ascorbate free radicals; Cancer; Ceruloplasmin; Doxorubicin; Electron spin resonance; Transferrin

Indexed keywords

ASCORBIC ACID; CARRIER PROTEIN; CERULOPLASMIN; COPPER; DOXORUBICIN; FREE RADICAL; HYDROGEN PEROXIDE; HYDROXYL RADICAL; IRON; TRANSFERRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD ANALYSIS; CANCER CHEMOTHERAPY; COMPLEX FORMATION; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; ENZYME ACTIVITY; LYMPHOMA; MALE; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; REGULATORY MECHANISM;

ANIMALS; ANTINEOPLASTIC AGENTS; COPPER; DISEASE MODELS, ANIMAL; DOGS; DOXORUBICIN; ELECTRON SPIN RESONANCE SPECTROSCOPY; IRON; LYMPHOMA; MALE; ORGANOMETALLIC COMPOUNDS; REACTIVE OXYGEN SPECIES; TRANSFERRIN;

EID: 0037114488     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(02)01416-8     Document Type: Article

References (33)

1. Carter S.K. Adriamycin: a review. J. Natl. Cancer Inst. 55:1975;1256-1274.
2. Khanna C., Lund E.M., Redic K.A., Hayden D.W., Bell F.W., Goulland E.L., Klausner J.S. Randomized controlled trial of doxorubicin versus dactinomycin in a multiagent protocol for treatment of dogs with malignant lymphoma. J. Am. Vet. Med. Assoc. 213:1998;985-990.
3. Sokolove P.M. Interactions of adriamycin aglycones with mitochondria may mediate adriamycin cardiotoxicity. Int. J. Biochem. 26:1994;1341-1350.
4. Gille L., Nohl H. Analyses of the molecular mechanism of adriamycin-induced cardiotoxicity. Free Radic. Biol. Med. 23:1997;775-782.
5. Nohl H., Gille L., Staniek K. The exogenous NADH dehydrogenase of heart mitochondria is the key enzyme responsible for selective cardiotoxicity of anthracyclines. Z. Naturforsch. C. 53:1998;279-285.
6. Malisza K.L., Hasinoff B.B. Production of hydroxyl radical by iron(III)-anthraquinone complexes through self-reduction and through reductive activation by the oxidase/hypoxanthine system. Arch. Biochem. Biophys. 321:1995;51-60.
7. Licata S., Saponiero A., Mordente A., Minotti G. Doxorubicin metabolism and toxicity in human myocardium: role of cytoplasmic deglycosidation and carbonyl reduction. Chem. Res. Toxicol. 13:2000;414-420.
8. Minotti G., Cairo G., Monti E. Role of iron in anthracycline cardiotoxicity: new tunes for an old song? FASEB J. 13:1999;199-212.
9. Herman E.H., Ferrans V.J. Preclinical animal models of cardiac protection from anthracycline-induced cardiotoxicity. Semin. Oncol. 25:1998;15-21.
10. Lieu P.T., Heiskala M., Peterson P.A., Yang Y. The roles of iron in health and disease. Mol. Aspects Med. 22:2001;1-87.
11. Mordente A., Meucci E., Martorana G.E., Giardina B., Minotti G. Human heart cytosolic reductases and anthracycline cardiotoxicity. IUBMB Life. 52:2001;83-88.
12. Price G.S., Page R.L., Fischer B.M., Levine J.F., Gerig T.M. Efficacy and toxicity of doxorubicin/cyclophosphamide maintenance therapy in dogs with multicentric lymphosarcoma. J. Vet. Intern. Med. 5:1991;259-262.
13. Sokolove P.M., Kester M.B., Haynes J. Interaction of adriamycin aglycones with isolated mitochondria. Effect of selenium deficiency. Biochem. Pharmacol. 46:1993;691-697.
14. Alderton P.M., Gross J., Green M.D. Comparative study of doxorubicin, mitoxantrone, and epirubicin in combination with ICRF-187 (ADR-529) in a chronic cardiotoxicity animal model. Cancer Res. 52:1992;194-201.
15. Miura T., Muraoka S., Ogiso T. Adriamycin-induced lipid peroxidation of erythrocyte membranes in the presence of ferritin and the inhibitory effect of ceruloplasmin. Biol. Pharm. Bull. 16:1993;664-667.
16. Henschler D. Chelatbildende stoffe. In: Forth W, Henschler D, Rummel W, Starke K, editors. Allgemeine und Spezielle Pharmakologie und Toxikologie. Heidelberg: Spektrum Akademischer Verlag; 1996, p. 836-7.
17. Solter P.F., Hoffmann W.E., Hungerford L.L., Siegel J.P., St. Denis S.H., Dorner J.L. Haptoglobin and ceruloplasmin as determinants of inflammation in dogs. Am. J. Vet. Res. 52:1991;1738-1742.
18. Floris G., Medda R., Padiglia A., Musci G. The physiopathological significance of ceruloplasmin. A possible therapeutic approach. Biochem. Pharmacol. 60:2000;1735-1741.
19. 2+) and transferrin in pleural effusions of lung diseases. Pathophysiology. 7:2000;41-45.
20. Dodd N.J.F., Silcock J.M. Electron spin resonance study of changes during development of solid yoshida tumor. II. Paramagnetic metal ions. Br. J. Cancer. 34:1976;556-565.
21. Dodd N.J., Silcock J.M. ESR study of development of RFM/Un murine myeloid leukaemia. Br. J. Cancer. 38:1978;612-618.
22. Dodd N.J.F. Electron spin resonance study of changes during the development of a mouse myeloid leukemia. I. Paramagnetic metal ions. Br. J. Cancer. 32:1975;108-120.
23. Horn R.A., Friesen E.J., Stephens R.L., Hedrick W.R., Zimbrick J.D. Electron spin resonance studies on properties of ceruloplasmin and transferrin in blood from normal human subjects and cancer patients. Cancer. 43:1979;2392-2398.
24. Hughes N.R. Serum transferrin and ceruloplasmin concentrations in patients with carcinoma, melanoma, sarcoma and cancers of haematopoietic tissues. Aust. J. Exp. Biol. Med. Sci. 50:1972;97-107.
25. McArdle H.J. The metabolism of copper during pregnancy - a review. Food Chem. 54:1995;79-84.
26. Atanasiu R.L., Stea D., Mateescu M.A., Vergely C., Dalloz F., Briot F., Maupoil V., Nadeau R., Rochette L. Direct evidence of ceruloplasmin antioxidant properties. Mol. Cell Biochem. 189:1998;127-135.
27. Lovstad R.A. The protective action of ceruloplasmin on copper ion stimulated lysis of rat erythrocytes. Int. J. Biochem. 14:1982;585-589.
28. 3+. Clin. Chem. 33:1987;405-407.
29. May P.M., Williams G.K., Williams D.R. Solution chemistry studies of adriamycin-iron complexes present in vivo. Eur. J. Cancer. 16:1980;1275-1276.
30. May J.M., Qu Z., Cobb C.E. Recycling of the ascorbate free radical by human erythrocyte membranes. Free Radic. Biol. Med. 31:2001;117-124.
31. Musci G., Bonaccorsi di Patti M.C., Calabrese L. The state of the copper sites in human ceruloplasmin. Arch. Biochem. Biophys. 306:1993;111-118.
32. Takeda K., Haida M., Shioya S., Matsumori T., Kimura Y., Hasumi K. Estimation of the malignancy of pleural effusions by electron spin resonance. Anal. Biochem. 241:1996;47-50.
33. Sharma M.K., Buettner G.R. Interaction of Vitamin C and Vitamin E during free radical stress in plasma: an ESR study. Free Radic. Biol. Med. 14:1993;649-653.